TOP-1288 Uses, Dosage, Side Effects and more
TOP-1288 is under investigation in clinical trial NCT02888379 (Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis).
| Trade Name | TOP-1288 |
| Generic | TOP-1288 |
| Type | |
| Formula | C43H49N7O9S |
| Weight | Average: 839.97 Monoisotopic: 839.33124736 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
